… , Inc. (NASDAQ:BCLI) Q3 2019 Earnings Conference Call November 14, 2019 … everyone on the third quarter earnings call. Let me begin by … problems that our process like Dendreon’s PROVENGE ran into because … of stem cell also. And Dendreon isn’t a bad example …

… (NASDAQ:ZIOP) Q2 2019 Earnings Call August 8, 2019, 8 … Ziopharm Oncology second quarter 2019 earnings call. At this time … management at Immunex and Dendreon. Her entrepreneurial experience as … More ZIOP analysis All earnings call transcripts This article …

… , Inc. (NASDAQ:ZIOP) Q2 2019 Earnings Conference Call August 8, 2019 … Ziopharm Oncology Second Quarter 2019 Earnings Call. At this time, all … operations management at Immunex and Dendreon, her entrepreneurial experience as Co …

… should have seen our earnings press release. The corresponding … as Allergan, Zimmer Biomet and Dendreon. Mr. Kemp' … Zimmer Biomet and most recently, Dendreon. Over that time frame, … corporate update and fourth quarter earnings conference call. To reiterate …

… NYSE:BHC) Q2 2018 Results Earnings Conference Call August 7, … Bausch Health second-quarter 2018 earnings call. [Operator instructions] Thank … to the divestiture of Dendreon, which is in the … of our divested businesses, including Dendreon, Obagi and Women…

… measures, the company's earnings release and supplemental information package … also can you talk about Dendreon, which looks likes it… and tackling. As far as Dendreon, that comes up I think … the current owner of the Dendreon business has been making an …

… to the impact of the Dendreon divestiture. Below the gross profit … effective tax rate on adjusted earnings for 2018. After giving effect … and sustainable rate on adjusted earnings. As a result, we… a significant proportion of our earnings into cash. And we …

… our members before the earnings. We provided an earnings update at the … upcoming potential catalyst is Q3 earnings report. It would be interesting … pile. It completed sale of Dendreon Pharmaceuticals LLC in June and …

… due to the divestiture of Dendreon Pharmaceuticals LLC. This was … stocks here. Ligand’s earnings per share estimates have moved … The company delivered positive earnings surprises in two of the … . The company reported positive earnings surprises in three of the …

… Corporation (NASDAQ:MNKD) Q3 2017 Earnings Conference Call November 07, 2017 … seen in conjunction with our earnings call announcement today. We … , that did this was Dendreon and for them it was … a very big difference than Dendreon which is treating in …